Epidermal growth factor receptor (EGFR) antibodies (panitumumab and cetuximab) and EGFR tyrosine kinase inhibitors (TKIs; gefitinib, erlotinib, afatinib, osimertinib, and dacomitinib) cause various skin disorders. The gene discussed is EGFR; the disease is skin disorder.